HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.

Abstract
Therapy-responsive biomarkers are an important and unmet need in the muscular dystrophy field where new treatments are currently in clinical trials. By using a comprehensive high-resolution mass spectrometry approach and western blot validation, we found that two fragments of the myofibrillar structural protein myomesin-3 (MYOM3) are abnormally present in sera of Duchenne muscular dystrophy (DMD) patients, limb-girdle muscular dystrophy type 2D (LGMD2D) and their respective animal models. Levels of MYOM3 fragments were assayed in therapeutic model systems: (1) restoration of dystrophin expression by antisense oligonucleotide-mediated exon-skipping in mdx mice and (2) stable restoration of α-sarcoglycan expression in KO-SGCA mice by systemic injection of a viral vector. Following administration of the therapeutic agents MYOM3 was restored toward wild-type levels. In the LGMD model, where different doses of vector were used, MYOM3 restoration was dose-dependent. MYOM3 fragments showed lower inter-individual variability compared with the commonly used creatine kinase assay, and correlated better with the restoration of the dystrophin-associated protein complex and muscle force. These data suggest that the MYOM3 fragments hold promise for minimally invasive assessment of experimental therapies for DMD and other neuromuscular disorders.
AuthorsJérémy Rouillon, Jérôme Poupiot, Aleksandar Zocevic, Fatima Amor, Thibaut Léger, Camille Garcia, Jean-Michel Camadro, Brenda Wong, Robin Pinilla, Jérémie Cosette, Anna M L Coenen-Stass, Graham Mcclorey, Thomas C Roberts, Matthew J A Wood, Laurent Servais, Bjarne Udd, Thomas Voit, Isabelle Richard, Fedor Svinartchouk
JournalHuman molecular genetics (Hum Mol Genet) Vol. 24 Issue 17 Pg. 4916-32 (Sep 01 2015) ISSN: 1460-2083 [Electronic] England
PMID26060189 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2015. Published by Oxford University Press.
Chemical References
  • Biomarkers
  • Blood Proteins
  • Connectin
  • MYOM3 protein, human
  • Creatine Kinase
Topics
  • Adolescent
  • Adult
  • Animals
  • Biomarkers
  • Blood Proteins (metabolism)
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Connectin (blood, metabolism)
  • Creatine Kinase
  • Disease Models, Animal
  • Humans
  • Mass Spectrometry
  • Mice
  • Mice, Inbred mdx
  • Muscular Dystrophies (blood, metabolism, therapy)
  • Muscular Dystrophy, Duchenne (blood, metabolism)
  • Proteomics (methods)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: